These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23567763)

  • 21. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators.
    Berger RD; Lerew DR; Smith JM; Pulling C; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):749-53. PubMed ID: 16836672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable defibrillators for life threatening ventricular arrhythmias. Are more effective than antiarrhythmic drugs in selected high risk patients.
    Causer JP; Connelly DT
    BMJ; 1998 Sep; 317(7161):762-3. PubMed ID: 9740558
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating electrical instability in sudden cardiac death survivors -- are we looking at the right side of the coin?
    Weber H; Allikmets K; Kornfeld G
    Eur Heart J; 2004 Apr; 25(8):623-5. PubMed ID: 15084363
    [No Abstract]   [Full Text] [Related]  

  • 24. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MADIT-II: substudies and their implications.
    Moss AJ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):430-3. PubMed ID: 15071269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of implantable cardioverter-defibrillators: from trials to the real world.
    De Sousa J
    Rev Port Cardiol; 2005 Apr; 24(4):501-4. PubMed ID: 15977774
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefits of implantable cardiac defibrillators in heart failure are confirmed.
    Tanne JH
    BMJ; 2004 Mar; 328(7441):664. PubMed ID: 15031233
    [No Abstract]   [Full Text] [Related]  

  • 28. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
    J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of implantable cardioverter-defibrillators. Problems and progress in the design of randomized trials.
    Mower MM; Thomas AC; Nisam S; Graf AJ
    J Electrocardiol; 1993; 26 Suppl():42-50. PubMed ID: 8189144
    [No Abstract]   [Full Text] [Related]  

  • 30. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillators confer survival benefit in patients with chronic obstructive pulmonary disease.
    Razak E; Kamireddy S; Saba S
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1125-30. PubMed ID: 20487355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

  • 34. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee.
    Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease.
    Goldenberg I; Moss AJ
    Clin Geriatr Med; 2007 Feb; 23(1):205-19. PubMed ID: 17126763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of arrhythmias by implantable automatic defibrillators].
    Fromer M
    Rev Med Suisse Romande; 1999 May; 119(5):395-7. PubMed ID: 10384774
    [No Abstract]   [Full Text] [Related]  

  • 40. A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients.
    Tang AS; Ellenbogen KA
    Curr Opin Cardiol; 2006 Mar; 21(2):78-82. PubMed ID: 16470139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.